We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
Cap. Flow
-$4.15B
Cap. Flow %
-9.34%
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$309M
2
XOM icon
ExxonMobil
XOM
+$302M
3
AMZN icon
Amazon
AMZN
+$291M
4
C icon
Citigroup
C
+$253M
5
SHOP icon
Shopify
SHOP
+$238M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$383M
2
JNJ icon
Johnson & Johnson
JNJ
+$312M
3
JPM icon
JPMorgan Chase
JPM
+$285M
4
T icon
AT&T
T
+$191M
5
DG icon
Dollar General
DG
+$187M

Sector Composition

Rank Sector Weight
1 Healthcare 15.63%
2 Financials 15.61%
3 Technology 14.28%
4 Consumer Discretionary 13.21%
5 Industrials 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SOL
1651
DELISTED
Emeren Group
SOL
$2.22M 0.01%
491,394
-51,796
-10% -$239K
KNSA icon
1652
Kiniksa Pharmaceuticals
KNSA
$6.11B
$2.22M 0.01%
+147,939
New +$2.15M
BNAI
1653
Brand Engagement Network
BNAI
$83.3M
$2.22M 0.01%
21,976
AVACW
1654
CALL
DELISTED
Avalon Acquisition Inc. Warrant
AVACW
$2.21M 0.01%
215,853
OPA.WS
1655
CALL
DELISTED
Magnum Opus Acquisition Limited Redeemable Warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50
OPA.WS
$2.21M 0.01%
219,314
-260,686
-54% -$16.7K
GES
1656
DELISTED
Guess Inc
GES
$2.21M 0.01%
+106,770
New +$1.96M
CCV.WS
1657
CALL
DELISTED
Churchill Capital Corp V Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
CCV.WS
$2.21M 0.01%
221,957
GOSS icon
1658
Gossamer Bio
GOSS
$100M
$2.2M 0.01%
1,015,450
+515,894
+103% +$4.25M
NSA
1659
DELISTED
National Storage Affiliates Trust
NSA
$2.2M ﹤0.01%
+60,777
New +$2.38M
MODN
1660
DELISTED
MODEL N, INC.
MODN
$2.19M ﹤0.01%
54,094
-91,701
-63% -$3.45M
HBAN icon
1661
Huntington Bancshares
HBAN
$35B
$2.19M ﹤0.01%
+155,140
New +$2.25M
VMGAW
1662
CALL
DELISTED
VMG Consumer Acquisition Corp. Warrant
VMGAW
$2.18M ﹤0.01%
212,499
WPC icon
1663
W.P. Carey
WPC
$16.8B
$2.18M ﹤0.01%
28,475
+17,040
+149% +$1.28M
PNST.WS
1664
CALL
DELISTED
Pinstripes Holdings, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
PNST.WS
$2.17M ﹤0.01%
212,499
GWRE icon
1665
Guidewire Software
GWRE
$13.3B
$2.17M ﹤0.01%
34,664
-29
-0.1% -$1.72K
APMI
1666
DELISTED
AxonPrime Infrastructure Acquisition Corporation Class A Common Stock
APMI
$2.16M ﹤0.01%
218,585
BWCAW
1667
CALL
DELISTED
Blue Whale Acquisition Corp I Warrant
BWCAW
$2.15M ﹤0.01%
219,105
FERG icon
1668
Ferguson
FERG
$45B
$2.14M ﹤0.01%
16,861
+8,896
+112% +$1.04M
AFTR.WS
1669
CALL
DELISTED
AfterNext HealthTech Acquisition Corp Warrants
AFTR.WS
$2.14M ﹤0.01%
213,399
MYGN icon
1670
Myriad Genetics
MYGN
$502M
$2.13M ﹤0.01%
+147,004
New +$2.74M
ACBAW
1671
CALL
DELISTED
Ace Global Business Acquisition Ltd Warrant
ACBAW
$2.13M ﹤0.01%
200,548
ATCO
1672
DELISTED
Atlas Corp.
ATCO
$2.13M ﹤0.01%
138,713
-583,561
-81% -$8.81M
ZETA icon
1673
Zeta Global
ZETA
$5.46B
$2.13M ﹤0.01%
260,287
+187,816
+259% +$1.52M
ADP icon
1674
PUT
Automatic Data Processing
ADP
$106B
$2.13M ﹤0.01%
8,900
+700
+9% +$172K
WPCB.WS
1675
CALL
DELISTED
Warburg Pincus Capital Corporation I-B Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
WPCB.WS
$2.12M ﹤0.01%
210,525

Similar funds

Marshall Wace's Q4 2022 Portfolio in Review

As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.

  • Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
  • Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
  • Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
  • Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
  • Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
  • Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
  • Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.